
Motus GI Investor Relations Material
Latest events

Q3 2022
Motus GI

Q1 2024
14 May, 2024

Q4 2023
18 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Motus GI Holdings Inc
Access all reports
Motus GI Holdings, Inc. is a medical technology company specializing in the development of solutions to enhance the effectiveness of colonoscopy procedures. The company’s flagship product is a system designed to improve visualization during colonoscopies by facilitating the removal of bowel contents, which helps in detecting abnormalities and reduces the need for repeat procedures. Motus GI primarily serves healthcare providers and aims to improve patient outcomes and procedural efficiency in gastrointestinal care. The company is headquartered in Fort Lauderdale, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
MOTS
Country
🇺🇸 United States